Patients with differentiated thyroid cancer treated with the GLP-1s showed no increased risk of recurrence over a more than 5-year follow-up.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1s-dont-raise-dtc-recurrence-risk-study-says-2025a1000o8o?src=rss
Author :
Publish date : 2025-09-12 17:44:00
Copyright for syndicated content belongs to the linked Source.
